BiotechTube
Home/Noa Therapeutics/Serena Mandla, P.Eng, MASc
SM

Serena Mandla, P.Eng, MASc

CSO & Co‑Founder

Noa Therapeutics

Therapeutic Areas

ImmunologyGastroenterologyDermatology

Noa Therapeutics Pipeline

DrugIndicationPhase
Noa‑001Inflammatory Bowel DiseasePreclinical
Noa‑002Chronic Inflammatory Skin DisordersPreclinical

Leadership Team at Noa Therapeutics

CS
Carla Spina, PhD
CEO & Co‑Founder
KK
Kathy Kordy, MD
CMO
TD
Troy Dale, MBA
Acting CBO
View full Noa Therapeutics profile